While many use marijuana for managing chronic pain or as a way to unwind at the end of the day, according to UW Medicine, ...

From CMS developments to device coverage, here are 10 payer updates spine surgeons should know headed into 2026: 1. Some fee-for-service spine procedures in traditional Medicare will have prior ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Health-related social needs in HF, removing age from frailty scores, CIED concerns about smartwatches, and more.

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Discover the top 10 surprising virtual assistant services to outsource in 2025, redefining the way you manage tasks smoothly.

In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of ...

Next year is bringing many changes to the regulatory landscape for skilled nursing. With new payment rules, coding changes ...